News Releases


2017 | 2016 | 2015 | Archive
Keyword Search
 
DateTitle 
03/30/17ACADIA Pharmaceuticals Announces Appointment of Michael J. Yang as Executive Vice President, Chief Commercial Officer
Terrence O. Moore Retires as Chief Commercial Officer SAN DIEGO--(BUSINESS WIRE)--Mar. 30, 2017-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced Michael J. Yang has joined ACADIA as Executive Vice President and Chief Commercial Officer. Mr. Yang succeeds Terr... 
Printer Friendly Version
03/29/17ACADIA Pharmaceuticals to Present at Needham & Company’s 16th Annual Healthcare Conference on April 5, 2017
SAN DIEGO--(BUSINESS WIRE)--Mar. 29, 2017-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at Needham & Company’s 16th Annual Healthcare Conference on Wednesday, April 5, 2017, at 10:40 a.m. Eastern Time in New York City. A live webca... 
Printer Friendly Version
02/28/17ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016
NUPLAZID® Net Product Sales Grew to $12.0 Million in Fourth Quarter 2016 Executing on Broad Clinical Development Program in Alzheimer’s Disease Psychosis, Alzheimer’s Disease Agitation, Schizophrenia Inadequate Response, Negative Symptoms of Schizophrenia, and Major Depressive Disorder SAN DIEGO--(BUSINESS WIRE)--Feb. 28, 2017-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development an... 
Printer Friendly Version
02/27/17ACADIA Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference on March 6, 2017
SAN DIEGO--(BUSINESS WIRE)--Feb. 27, 2017-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the Cowen and Company 37th Annual Health Care Conference on Monday, March 6, 2017, at 1:20 p.m. Eastern Time in Boston. A live webcast of ACADIA... 
Printer Friendly Version
02/21/17ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2016 Financial Results on February 28, 2017
ACADIA to Host Conference Call and Webcast on Tuesday, February 28, 2017, at 5:00 p.m. Eastern Time SAN DIEGO--(BUSINESS WIRE)--Feb. 21, 2017-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its financial results for the fourth quarter and yea... 
Printer Friendly Version
01/03/17ACADIA Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference on January 10, 2017
SAN DIEGO--(BUSINESS WIRE)--Jan. 3, 2017-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the 35th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017, at 1:30 pm Pacific Time in San Francisco. A live webcast of ACADI... 
Printer Friendly Version